Recombinant Human ART4 Protein，His

ART4, a member of the ART (ADP-ribosyltransferase) family, has garnered attention in recent years due to its unique enzymatic properties and potential implications in cell signaling, immune response, and disease processes. This protein is known to catalyze the transfer of ADP-ribose from NAD+ to target proteins, a post-translational modification that can significantly alter protein function and regulate various cellular pathways. Research indicates that ART4 plays a pivotal role in modulating immune cell activation, particularly in the context of T lymphocytes, by influencing their proliferation and differentiation. Additionally, aberrant expression or activity of ART4 has been linked to various pathological conditions, including autoimmune diseases and cancers, leading to an increasing interest in its role as a therapeutic target. Understanding the molecular mechanisms underlying ART4’s function could provide valuable insights into potential interventions for these diseases. Recent studies utilizing advanced protein engineering and structural biology techniques have begun to unravel the intricacies of ART4's active site and how it interacts with substrates, which could pave the way for the development of specific inhibitors or modulators. Overall, the exploration of ART4 and its biochemical pathways not only broadens our understanding of protein modifications in cellular biology but also holds promise for new therapeutic strategies in the treatment of diseases associated with dysregulated ADP-ribosylation.